Table 2.
Control, n = 67 | VNS, n = 43 | |
---|---|---|
Anticonvulsant drugs | ||
Brivaracetam | ø | X |
Carbamazepine | ø | X |
Clobazam | ø | X |
Eslicarbazepine | ø | X |
Gabapentin | ø | X |
Lacosamide | X | X |
Lamotrigine | X | X |
Levetiracetam | X | X |
Oxcarbazepine | X | X |
Phenytoin | X | X |
Primidone | ø | X |
Topiramate | ø | X |
Valproate | ø | X |
Zonisamide | X | X |
Benzodiazepines | ||
Alprazolam | ø | X |
Clonazepam | X | X |
Diazepam | ø | X |
Lorazepam | X | X |
A broader range of anticonvulsant drugs and benzodiazepines was needed to control seizures in the VNS compared to the control group. ø: none of the patients in the respective group was treated with the drug; X: at least one patient in the respective group was treated with the drug.